CTX611
Live / Applied — New application — not yet assigned to an examiner (as of 07 Jan 2026)
What this means for you
Not registered yet, but its 07 Jan 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99583006
- Mark type
- Stylized text
- Filed
- 07 Jan 2026
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use in the field of gene therapy for the treatment of cardiovascular diseases and thromboembolic diseases and disorders; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular diseases and thromboembolic diseases and disorders in the field of gene therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular diseases and thromboembolic diseases and disorders in the field of gene therapy
- Class 042 — Scientific and technological services: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of gene therapy
Owner
- CRISPR Therapeutics AG, ZUG V8, CH
Prosecution history
- 07 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 07 Jan 2026 — NEW APPLICATION ENTERED